![Chemical structure of 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)-, CAS 123948-87-8](https://api.angenesci.com/structure/3918/123948-87-8.png)
No data
No data
No data
| CAS Number | 123948-87-8 |
| Catalog Number | AG000L9E(AGN-PC-0PHPJA) |
| Chemical Name | 1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)- |
| IUPAC Name | (19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione |
| InChI | InChI=1S/C23H23N3O5/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20/h5-8,27,30H,4,9-11H2,1-3H3/t23-/m0/s1 |
| InChI Key | UCFGDBYHRUNTLO-QHCPKHFHSA-N |
| MDL Number | MFCD00870670 |
| Molecular Formula | C23H23N3O5 |
| Molecular Weight | 421.4458 |
| NSC Number | 641007 |
| SMILES | O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=CC5=C(CN(C)C)C(O)=CC=C5N=C4C3=C2)=O |
| UNII | 7M7YKX2N15 |
| Synonyms | 9 Dimethylaminomethyl 10 hydroxycamptothecin,
9-Dimethylaminomethyl-10-hydroxycamptothecin,
Hycamtamine,
Hycamtin,
Hydrochloride, Nogitecan,
Hydrochloride, Topotecan,
Nogitecan Hydrochloride,
NSC 609699,
NSC-609699,
NSC609699,
SK and F 104864 A,
SK and F-104864-A,
SK and F104864A,
SKF 104864 A,
SKF-104864-A,
SKF104864A,
Topotecan,
Topotecan Hydrochloride,
Topotecan Monohydrochloride, (S)-Isomer,
topotecan,
123948-87-8,
Hycamtin,
Topotecan lactone,
Hycamptamine,
Topotecane,
Topotecanum,
Hycamtamine,
Topotecane [INN-French],
Topotecanum [INN-Latin],
(S)-Topotecan,
Hycamptin,
Topotecan [INN:BAN],
SKF-104864-A,
SK&F-104864-A,
9-Dimethylaminomethyl-10-hydroxycamptothecin,
UNII-7M7YKX2N15,
C23H23N3O5,
CHEMBL84,
NSC609699,
Hycamtin (TN),
7M7YKX2N15,
CHEBI:63632,
SK-S-104864-A,
(4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,
(S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione,
(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE,
Nogitecan,
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)-,
9-[(dimethylamino)methyl]-10-hydroxy-(4S)-camptothecin,
CHEMBL1607,
Topophore C,
Topotecan Actavis,
TopoCED,
Topotecan (BAN),
(S)-10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione,
(S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,
1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-, (S)-,
SK&F-S-104864A,
SR-01000763672,
TOPOTECAN, HYCAMTIN,
SK&F 104864 A,
9-Dimethylaminomethyl-10-hydroxycamptothecin.,
Topotecan Monohydrochloride, (S)-Isomer,
CCRIS 8163,
MFCD00870670,
HSDB 8213,
1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (S)-,
SKF-S 104864,
SKF 104864,
AC1L1TQZ,
AC1Q6APZ,
SCHEMBL3836,
NCIStruc1_001659,
NCIStruc2_001796,
BSPBio_002348,
cid_60699,
GTPL7101,
DTXSID3042685,
KS-00000PLT,
EX-A834,
UCFGDBYHRUNTLO-QHCPKHFHSA-N,
HMS2090B20,
HMS3715L03,
ZINC1611274,
BDBM50008935,
BDBM50034026,
HSCI1_000228,
NSC641007,
AKOS015966792,
API0004452,
AT-2921,
CCG-221171,
CS-2887,
DB01030,
NSC-641007,
SMP2_000312,
SMP2_000327,
NCGC00014925-02,
NCGC00014925-03,
NCGC00014925-04,
NCGC00014925-07,
NCGC00014925-10,
NCGC00178695-01,
(S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione,
AC-11592,
AJ-90579,
AK-72818,
AN-32741,
CC-35105,
HY-13768,
M965,
NCI60_004771,
AB0015476,
AX8224399,
LS-127395,
B4982,
dimethylaminomethyl-ethyl-dihydroxy-[?]dione,
FT-0654504,
ST24026008,
ST24031920,
T-161,
A16815,
C11158,
D08618,
W-1887,
AB00641837-09,
AB00641837-11,
AB00641837-12,
AB00641837-13,
AB00641837-14,
AB00641837_15,
AB00641837_16,
948T878,
C-22083,
SR-01000763672-3,
SR-01000763672-4,
BRD-K55696337-001-03-2,
BRD-K55696337-003-08-7,
Topotecan hydrochloride hydrate, >=98% (HPLC and enzymatic),
(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0;{2,11}.0;{4,9}.0;{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione,
(20S)-10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione,
(4-Ethyl-4,9-dihydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-10-ylmethyl)-dimethyl-ammonium,
(alphaS)-alpha,8-Dihydroxy-1(11H)-oxo-alpha-ethyl-2-(hydroxymethyl)-9-(dimethylaminomethyl)-5,11a-diaza-11aH-benzo[b]fluorene-3-acetic acid 3,2-lactone,
(alphaS)-alpha-Hydroxy-8-oxylato-1(11H)-oxo-alpha-ethyl-2-(hydroxymethyl)-9-(dimethylaminiomethyl)-5,11a-diaza-11aH-benzo[b]fluorene-3-acetic acid 3,2-lactone,
(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3'''',4'''':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE,
(S)-10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione,
(S)-10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione; hydrochloride,
(S)-11-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione,
(S)-11-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione; hydrochloride,
10-dimethylaminomethyl-4-ethyl-4,9-dihydroxy-(4S)-3,4,12,14-tetrahydro-1H-pyrano[3'''',4'''':6,7]indolizino[1,2-b]quinoline-3,14-dione,
10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione,
10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (Topotecan),
10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione(Topotecan),
10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione; hydrochloride,
1H-Pyrano[3',7]indolizino[1,2-b]quinoline- 3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)-,
Topotecan Hcl,
potactasol,
nogitecan HCl,
Topotecan SUN,
Topotecan Hospira,
TOPOTECAN HYDROCHLORIDE,
Nogitecan hydrochloride,
Hydrochloride, Nogitecan,
Hydrochloride, Topotecan,
D02PMO,
NSC 609699,
SKF104864A,
NSC-609699,
CID60700,
SK&F104864A,
SK&F S-104864-A,
SKF 104864 A,
C23-H23-N3-O5,
ACN-057092,
CS-O-02414,
1749B,
9 Dimethylaminomethyl 10 hydroxycamptothecin,
D019772,
119413-54-6,
9-[(dimethylamino)methyl]-10-hydroxy-(20S)-camptothecin,
TTC,
TPT,
4-Ethyl-4,9-dihydroxy-10-[(dimethylamino)methyl]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,
|
| Complexity | 867 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 421.164g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 31 |
| Hydrogen Bond Acceptor Count | 7 |
| Hydrogen Bond Donor Count | 2 |
| Isotope Atom Count | 0 |
| Molecular Weight | 421.453g/mol |
| Monoisotopic Mass | 421.164g/mol |
| Rotatable Bond Count | 3 |
| Topological Polar Surface Area | 103A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 0.5 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302 |
| Packing Group | |
| Precautionary statements | P280-P305+P351+P338 |
| UN Code | \N |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

